Regulation (EU) No 1178/2011 AIRCREW : Pilot Licenses
Revision from August 2023
- EASA - AIRCREW :
- FRANCE :
Annexe VI : [PART MED] - Medical Requirements
SUBPART A – GENERAL REQUIREMENTS
Section 1 - GENERAL
MED.A.001 Competent authority - Regulation (EU) 2019/27
For the purpose of this Annex (Part-MED), the competent authority shall be:
- for aero-medical centres (AeMCs):
- the authority designated by the Member State, where the AeMC has its principal place
of business;
- the Agency, if the AeMC is located in a third country;
- for aero-medical examiners (AMEs):
- the authority designated by the Member State where the AME has its principal place
of practice;
- if the principal place of practice of an AME is located in a third country, the
authority
designated by the Member State to which the AME applies for the issue of the AME
certificate;
- for general medical practitioners (GMPs), the authority designated by the Member State to
which the GMP notify their activity;
- for occupational health medical practitioners (OHMPs) assessing the medical fitness of cabin
crew, the authority designated by the Member State to which the OHMP notify their activity.
MED.A.005 Scope - Regulation (EU) 2019/27
This Annex (Part-MED) establishes the requirements for:
- the issuance, validity, revalidation and renewal of the medical certificate required for
exercising
the privileges of a pilot licence or of a student pilot;
- the medical fitness of cabin crew;
- the certification of AMEs;
- the qualification of GMPs and OHMPs
MED.A.010 Definitions - Regulation (EU) 2019/27
For the purpose of this Annex (Part-MED), the following definitions shall apply:
- ‘limitation’ means a condition placed on the medical certificate or cabin crew medical
report
that shall be complied with whilst exercising the privileges of the licence or cabin crew
attestation;
- ‘aero-medical examination’ means an inspection, palpation, percussion, auscultation or any
other means of investigation for determining the medical fitness to exercise the privileges
of
the licence, or to carry out cabin crew safety duties;
- ‘aero-medical assessment’ means the conclusion on the medical fitness of an applicant based
on the evaluation of the applicant as required in this Annex (Part-MED) and further
examinations and medical tests as clinically indicated;
- ‘significant’ means a degree of a medical condition, the effect of which would prevent the
safe
exercise of the privileges of the licence or of the cabin crew safety duties;
- ‘applicant’ means a person applying for, or being the holder of, a medical certificate who
undergoes an aero-medical assessment of fitness to exercise the privileges of the licence,
or to
carry out cabin crew safety duties;
- ‘medical history’ means a narrative or record of past diseases, injuries, treatments or
other
medical facts, including unfit assessment(s) or limitation of a medical certificate, that
are or may
be relevant to an applicant’s current state of health and aero-medical fitness;
- ‘licensing authority’ means the competent authority of the Member State that issued the
licence, or to which a person applies for the issuance of a licence, or, when a person has
not yet
applied for a licence, the competent authority as determined in accordance with FCL.001 of
Annex I (Part-FCL);
- ‘colour safe’ means the ability of an applicant to readily distinguish the colours used in
air
navigation and to correctly identify aviation coloured lights;
- ‘investigation’ means the assessment of a suspected pathological condition of an applicant
by
means of examinations and tests in order to verify the presence or absence of a medical
condition;
- ‘accredited medical conclusion’ means the conclusion reached by one or more medical experts
acceptable to the licensing authority, on the basis of objective and non-discriminatory
criteria,
for the purposes of the case concerned, in consultation with flight operations or other
experts
as necessary, for which an operational risk assessment may be appropriate;
- ‘misuse of substances’ means the use of one or more psychoactive substances by aircrew in a
way that, alternatively or jointly:
- constitutes a direct hazard to the user or endangers the lives, health or welfare of
others;
- causes or worsens an occupational, social, mental or physical problem or disorder;
- ‘psychoactive substances’ means alcohol, opioids, cannabinoids, sedatives and hypnotics,
cocaine, other psychostimulants, hallucinogens, and volatile solvents, with the exception of
caffeine and tobacco;
- ‘refractive error’ means the deviation from emmetropia measured in dioptres in the most
ametropic meridian, measured by standard methods.
MED.A.015 Medical confidentiality - Regulation (EU) 2019/27
All persons involved in aero-medical examinations, assessments and certification shall ensure
that
medical confidentiality is respected at all times.
AMC1 MED.A.015 Medical confidentiality - ED Decision
2019/002/R
To ensure medical confidentiality, all medical reports and records should be securely held
with
accessibility restricted to personnel authorised by the medical assessor or, where
applicable, by the
head of the aero-medical centre (AEMC), the aero-medical examiner (AME), general medical
practitioner (GMP) or occupational health medical practitioner (OHMP).
MED.A.020 Decrease in medical fitness - Regulation (EU) 2019/27
- Licence holders shall not exercise the privileges of their licence and related ratings or
certificates, and student pilots shall not fly solo, at any time when they:
- are aware of any decrease in their medical fitness which might render them unable to
safely exercise those privileges;
- take or use any prescribed or non-prescribed medication which is likely to interfere
with
the safe exercise of the privileges of the applicable licence;
- receive any medical, surgical or other treatment that is likely to interfere with
the safe
exercise of the privileges of the applicable licence.
- In addition, holders of a medical certificate shall, without undue delay and before
exercising the
privileges of their licence, seek aero-medical advice from the AeMC, AME or GMP, as
applicable,
when they:
- have undergone a surgical operation or invasive procedure;
- have commenced the regular use of any medication;
- have suffered any significant personal injury involving incapacity to function as a
member
of the flight crew;
- have been suffering from any significant illness involving incapacity to function as
a
member of the flight crew;
- are pregnant;
- have been admitted to hospital or medical clinic;
- first require correcting lenses.
- In the cases referred to in point (b):
- holders of class 1 and class 2 medical certificates shall seek the aero-medical
advice of an
AeMC or AME. In that case, the AeMC or AME shall assess their medical fitness and
decide
whether they are fit to resume the exercise of their privileges;
- holders of light aircraft pilot licence medical certificates shall seek the
aero-medical
advice of an AeMC, an AME or the GMP who signed the medical certificate. In that
case,
the AeMC, AME or GMP shall assess their medical fitness and decide whether they are
fit
to resume the exercise of their privileges.
- Cabin crew members shall not perform duties on an aircraft and, where applicable, shall not
exercise the privileges of their cabin crew attestation when they are aware of any decrease
in
their medical fitness, to the extent that this medical condition might render them unable to
discharge their safety duties and responsibilities.
- In addition, if any of the medical conditions specified in points (1) to (5) of point (b)
apply, cabin
crew members shall, without undue delay, seek the advice of an AME, AeMC or OHMP, as
applicable. In that case, the AME, AeMC or OHMP shall assess the medical fitness of the
cabin
crew members and decide whether they are fit to resume their safety duties.
GM1 MED.A.020 Decrease in medical fitness - ED Decision
2019/002/R
MEDICATION – GUIDANCE FOR PILOTS AND CABIN CREW MEMBERS
- Any medication can cause side effects, some of which may impair the safe performance of
flying
duties. Equally, symptoms of colds, sore throats, diarrhoea and other abdominal upsets
may
cause little or no problem whilst on the ground but may distract the pilot or cabin crew
member
and degrade their performance whilst on duty. The in-flight environment may also
increase the
severity of symptoms which may only be minor whilst on the ground. Therefore, one issue
with
medication and flying is the underlying condition and, in addition, the symptoms may be
compounded by the side effects of the medication prescribed or bought over the counter
for
treatment. This guidance material provides some help to pilots and cabin crew in
deciding
whether expert aero-medical advice by an AME, AeMC, GMP, OHMP or medical assessor is
needed.
- Before taking any medication and acting as a pilot or cabin crew member, the following
three
basic questions should be satisfactorily answered:
- Do I feel fit to fly?
- Do I really need to take medication at all?
- Have I given this particular medication a personal trial on the ground to ensure
that it will
not have any adverse effects on my ability to fly?
- Confirming the absence of adverse effects may well need expert aero-medical advice.
- The following are some widely used medicines with a description of their compatibility
with
flying duties:
- Antibiotics. Antibiotics may have short-term or delayed side effects which can
affect pilot
or cabin crew performance. More significantly, however, their use usually
indicates that
an infection is present and, thus, the effects of this infection may mean that a
pilot or
cabin crew member is not fit to fly and should obtain expert aero-medical
advice.
- Anti-malaria drugs. The decision on the need for anti-malaria drugs depends on
the
geographical areas to be visited, and the risk that the pilot or cabin crew
member has of
being exposed to mosquitoes and of developing malaria. An expert medical opinion
should be obtained to establish whether anti-malaria drugs are needed and what
kind of
drugs should be used. Most of the anti-malaria drugs (atovaquone plus proguanil,
chloroquine, doxycycline) are compatible with flying duties. However, adverse
effects
associated with mefloquine include insomnia, strange dreams, mood changes,
nausea,
diarrhoea and headaches. In addition, mefloquine may cause spatial
disorientation and
lack of fine coordination and is, therefore, not compatible with flying duties.
- Antihistamines. Antihistamines can cause drowsiness. They are widely used in
‘cold cures’
and in treatment of hay fever, asthma and allergic rashes. They may be in tablet
form or
a constituent of nose drops or sprays. In many cases, the condition itself may
preclude
flying, so that, if treatment is necessary, expert aero-medical advice should be
sought so
that so-called non-sedative antihistamines, which do not degrade human
performance,
can be prescribed.
- Cough medicines. Antitussives often contain codeine, dextromethorfan or
pseudoephedrine which are not compatible with flying duties. However, mucolytic
agents (e.g.
carbocysteine) are well-tolerated and are compatible with flying duties.
- Decongestants. Nasal decongestants with no effect on alertness may be compatible
with
flying duties. However, as the underlying condition requiring the use of
decongestants
may be incompatible with flying duties, expert aero-medical advice should be
sought. For
example, oedema of the mucosal membranes causes difficulties in equalising the
pressure in the ears or sinuses.
- Nasal corticosteroids are commonly used to treat hay fever, and they are
compatible with
flying duties.
-
- Common pain killers and antifebrile drugs. Non-Steroidal
Anti-Inflammatory Drugs
(NSAIDs) and paracetamol, commonly used to treat pain, fever or
headaches, may
be compatible with flying duties. However, the pilot or cabin crew
member should
give affirmative answers to the three basic questions listed in (b)
before using the
medication and carrying out flying duties.
- Strong analgesics. The more potent analgesics including codeine are
opiate
derivatives, and may produce a significant decrement in human
performance and,
therefore, are not compatible with flying duties.
- Anti-ulcer medicines. Gastric secretion inhibitors such as H2 antagonists (e.g.
ranitidine,
cimetidine) or proton pump inhibitors (e.g. omeprazole) may be acceptable after
diagnosis of the pathological condition. It is important to seek for the medical
diagnosis
and not to only treat the dyspeptic symptoms.
- Anti-diarrhoeal drugs. Loperamide is one of the more common anti-diarrhoeal
drugs and
is usually safe to take whilst flying. However, the diarrhoea itself often makes
the pilot
and cabin crew member unfit for flying duties.
- Hormonal contraceptives and hormone replacement therapy usually have no adverse
effects and are compatible with flying duties.
- Erectile dysfunction medication. This medication may cause disturbances in
colour vision
and dizziness. There should be at least 6 hours between taking sildenafil and
flying duty;
and 36 hours between taking vardenafil or tadalafil and flying duty.
- Smoking cessation. Nicotine replacement therapy may be acceptable. However,
other
medication affecting the central nervous system (buproprion, varenicline) is not
acceptable for pilots.
- High blood pressure medication. Most anti-hypertensive drugs are compatible with
flying
duties. However, if the level of blood pressure is such that drug therapy is
required, the
pilot or cabin crew member should be monitored for any side effects before
carrying out
flying duties. Therefore, consultation with the AME, AeMC, GMP, OHMP or medical
assessor as applicable, is needed.
- Asthma medication. Asthma has to be clinically stable before a pilot or cabin
crew
member can return to flying duties. The use of respiratory aerosols or powders,
such as
corticosteroids, beta-2-agonists or chromoglycic acid may be compatible with
flying
duties. However, the use of oral steroids or theophylline derivatives is
incompatible with
flying duty. Pilots or cabin crew members using medication for asthma should
consult the
AME, AeMC, GMP, OHMP or medical assessor, as applicable.
- Tranquillisers and sedatives. The inability to react, due to the use of this
group of
medicines, has been a contributory cause to fatal aircraft accidents. In
addition, the
underlying condition for which these medications have been prescribed will
almost
certainly mean that the mental state of a pilot or cabin crew member is not
compatible
with flying duties.
- Sleeping tablets. Sleeping tablets dull the senses, may cause confusion and slow
reaction
times. The duration of effect may vary from individual to individual and may be
unduly
prolonged. Expert aero-medical advice should be obtained before using sleeping
tablets.
- Melatonin. Melatonin is a hormone that is involved with the regulation of the
circadian
rhythm. In some countries it is a prescription medicine, whereas in most other
countries
it is regarded as a ‘dietary supplement’ and can be bought without any
prescription. The
results from the efficiency of melatonin in treatment of jet lag or sleep
disorders have
been contradictory. Expert aero-medical advice should be obtained.
- Coffee and other caffeinated drinks may be acceptable, but excessive coffee
drinking may
have harmful effects, including disturbance of the heart’s rhythm. Other
stimulants
including caffeine pills, amphetamines, etc. (often known as ‘pep’ pills) used
to maintain
wakefulness or suppress appetite can be habit forming. Susceptibility to
different
stimulants varies from one individual to another, and all may cause dangerous
overconfidence. Overdosage causes headaches, dizziness and mental disturbance.
These
other stimulants should not be used.
- Anaesthetics. Following local, general, dental and other anaesthetics, a period
of time
should elapse before returning to flying. The period will vary considerably from
individual
to individual, but a pilot or cabin crew member should not fly for at least 12
hours after
a local anaesthetic, and for at least 48 hours after a general, spinal or
epidural anaesthetic
(see MED.A.020).
- Many preparations on the market nowadays contain a combination of medicines. It is,
therefore, essential that if there is any new medication or dosage, however slight, the
effect
should be observed by the pilot or the cabin crew member on the ground prior to flying.
It
should be noted that medication which would not normally affect pilot or cabin crew
performance may do so in individuals who are ‘oversensitive’ to a particular
preparation.
Individuals are, therefore, advised not to take any medicines before or during flight
unless they
are completely familiar with their effects on their own bodies. In cases of doubt,
pilots and cabin
crew members should consult an AME, AeMC, GMP, OHMP or medical assessor, as applicable.
- Other treatments
Alternative or complementary medicine, such as acupuncture, homeopathy, hypnotherapy and
several other disciplines, is developing and gaining greater credibility. Such
treatments are more
acceptable in some States than others. There is a need to ensure that ‘other
treatments’, as
well as the underlying condition, are declared and considered by the AME, AeMC, GMP,
OHMP
or medical assessor, as applicable, for assessing fitness.
MED.A.025 Obligations of the AeMC, AME, GMP and OHMP - Regulation (EU)
2019/27
- When conducting aero-medical examinations and aero-medical assessments as required in this
Annex (Part-MED), the AeMC, AME, GMP and OHMP shall:
- ensure that communication with the applicant can be established without language
barriers;
- make the applicant aware of the consequences of providing incomplete, inaccurate or
false statements on their medical history;
- notify the licensing authority, or, in the case of cabin crew attestation holders,
notify the
competent authority, if the applicant provides incomplete, inaccurate or false
statements
on their medical history;
- notify the licensing authority if an applicant withdraws the application for a
medical
certificate at any stage of the process.
- After completion of the aero-medical examinations and assessments, the AeMC, AME, GMP and
OHMP shall:
- inform the applicant whether he or she is fit, unfit or referred to the medical
assessor of
the licensing authority, AeMC or AME, as applicable;
- inform the applicant of any limitation that may restrict flight training or the
privileges of
his or her licence or cabin crew attestation, as applicable;
- if the applicant has been assessed as unfit, inform him or her of his or her right
to have
the decision reviewed in accordance with the procedures of the competent authority;
- in the case of applicants for a medical certificate, submit without delay to the
medical
assessor of the licensing authority a signed, or electronically authenticated,
report
containing the detailed results of the aero-medical examinations and assessments as
required for the class of medical certificate and a copy of the application form,
the
examination form, and the medical certificate;
- inform the applicant of his or her responsibilities in the case of decrease in
medical
fitness, as specified in point MED.A.020.
- Where consultation with the medical assessor of the licensing authority is required in
accordance with this Annex (Part-MED), the AeMC and AME shall follow the procedure
established by the competent authority.
- AeMCs, AMEs, GMPs and OHMPs shall maintain records with details of aero-medical
examinations and assessments performed in accordance with this Annex (Part-MED) and their
results for a minimum of 10 years, or for a longer period if so determined by national
legislation.
- AeMCs, AMEs, GMPs and OHMPs shall submit to the medical assessor of the competent
authority, upon request, all aero-medical records and reports, and any other relevant
information, when required for:
- medical certification;
- oversight functions.
- AeMCs and AMEs shall enter or update the data included in the European Aero-Medical
Repository in accordance with point (c) of point ARA.MED.160.
AMC1 MED.A.025 Obligations of the AeMC, AME, GMP and OHMP -
ED Decision 2019/002/R
- If the medical examination is carried out by two or more AMEs or GMPs, only one of them
should be responsible for coordinating the results of the examination, evaluating the
findings
with regard to medical fitness, and signing the report.
- The applicant should be made aware that the associated medical certificate or cabin crew
report
may be suspended or revoked if the applicant provides incomplete, inaccurate or false
statements on their medical history to the AeMC, AME, GMP or OHMP.
- In cases where the AeMC or AME is required to assess the fitness of an applicant for a
class 2
medical certificate in consultation with the medical assessor of the licensing
authority, they
should document the consultation in accordance with the procedure established by the
competent authority.
- The AeMC, AME, GMP or OHMP should give advice to the applicant on treatment and
preventive measures if, during the course of the examination, medical conditions or risk
factors
are identified which may endanger the medical fitness of the applicant in the future.
- When data is not being properly recorded in the European aero-medical data repository
(EAMR
due to unserviceability of the system, the AeMCs and AMEs should enter, or correct the
existing
data, in the EAMR without undue delay when the system recovers.
- In case of denial or referral to the licensing authority, the AeMC, AME, GMP or OHMP
should
inform the applicant in writing regarding the result of the assessment in a form and
manner
established by the competent authority.
GM1 MED.A.025 Obligations of the AeMC, AME, GMP and OHMP -
ED Decision 2019/002/R
GUIDELINES FOR THE AeMC, AME OR GMP CONDUCTING THE MEDICAL EXAMINATIONS AND ASSESSMENTS
FOR MEDICAL CERTIFICATION OF PILOTS
- Before performing the medical examination, the AeMC, AME or GMP should:
- verify the applicant’s identity by checking their identity card, passport,
driving licence or
other official document containing a photograph of the applicant;
- obtain details of the applicant’s flight crew licence from the applicant’s
licensing authority
if they do not have their licence with them;
- except for initial applicants, obtain details of the applicant’s most recent
medical
certificate from the medical assessor of the applicant’s licensing authority if
they do not
have their certificate with them;
- in the case of a specific medical examination(s) (SIC) limitation on the
existing medical
certificate, obtain details of the specific medical condition and any associated
instructions
from the medical assessor of the applicant’s licensing authority. This could
include, for
example, a requirement to undergo a specific examination or test;
- except for initial applicants, ascertain, from the previous medical certificate,
which
routine medical test(s) should be conducted, for example electrocardiography
(ECG);
- provide the applicant with the application form for a medical certificate and
the
instructions for completion and ask the applicant to complete the form but not
to sign it
yet;
- go through the form with the applicant and give information to help the
applicant
understand the significance of the entries and ask any questions which might
help the
applicant to recall important historical medical data;
- verify that the form is complete and legible, ask the applicant to sign and date
the form
and then sign it as well. If the applicant declines to complete the application
form fully,
inform the applicant that it may not be possible to issue a medical certificate
regardless
of the outcome of the clinical examination and assessment.
- Once all the items in (a) have been addressed, the AeMC, AME or GMP should:
- perform the medical examination of the applicant in accordance with the
applicable
rules;
- arrange for additional specialist medical examinations, such as
otorhinolaryngology (ENT)
or ophthalmology, to be conducted as applicable and obtain the associated report
forms
or reports;
- complete the medical examination report form in accordance with the associated
instructions for completion;
- ensure that all of the report forms are complete, accurate and legible.
- Once all the actions in (b) have been carried out, the AeMC, AME or GMP should review
the
report forms and:
- if satisfied that the applicant meets the applicable medical requirements as set
out in
Part-MED, issue a medical certificate for the appropriate class, with
limitations if
necessary. The applicant should sign the certificate once signed by the AeMC,
AME or
GMP; or
- if the applicant does not meet the applicable medical requirements, or if the
fitness of
the applicant for the class of medical certificate applied for is in doubt:
- refer the decision on medical fitness to, or consult the decision on
medical fitness
with, the medical assessor of the licensing authority or AME in
compliance with
MED.B.001; or
- deny issuance of a medical certificate, explain the reason(s) for denial
to the
applicant and inform them of their right of a review according to the
procedures
of the competent authority.
- The AeMC, AME or GMP should send the documents as required by MED.A.025(b) to the
medical assessor of the applicant’s licensing authority within 5 days from the date of
the
medical examination. If a medical certificate has been denied or the decision has been
referred,
the documents should be sent to the medical assessor of the licensing authority on the
same
day that the denial or referral decision is reached.
Section 2 - REQUIREMENTS FOR MEDICAL CERTIFICATES
MED.A.030 Medical certificates - Regulation (EU) 2020/359
- A student pilot shall not fly solo unless that student pilot holds a medical certificate, as
required
for the relevant licence.
- An applicant for a licence, in accordance with Annex I (Part-FCL), shall hold a medical
certificate
issued in accordance with this Annex (Part-MED) and appropriate to the licence privileges
applied for.
- When exercising the privileges of a:
- light aircraft pilot licence (LAPL), a balloon pilot licence (BPL) issued in
accordance with
Annex III (Part-BFCL) to Commission Regulation (EU) 2018/395, or a sailplane pilot
licence
(SPL) issued in accordance with Annex III (Part-SFCL) to Commission Implementing
Regulation (EU) 2018/1976, the pilot shall hold at least a valid LAPL medical
certificate;
- private pilot licence (PPL), the pilot shall hold at least a valid class 2 medical
certificate;
- BPL for the purpose of:
- commercial passenger ballooning, the pilot shall hold at least a valid class
2 medical
certificate;
- commercial operation other than commercial passenger ballooning, with more
than 4 persons on board the aircraft, the pilot shall hold at least a valid
class 2
medical certificate;
- SPL for the purpose of commercial sailplane operations other than those specified in
Article 3(2) of Commission Implementing Regulation (EU) 2018/1976, the pilot shall
hold
at least a valid class 2 medical certificate;
- a commercial pilot licence (CPL), a multi-crew pilot licence (MPL) or an airline
transport
pilot licence (ATPL), the pilot shall hold a valid class 1 medical certificate.
- If a night rating is added to a PPL or LAPL, the licence holder shall be colour safe.
- If an instrument rating or en route instrument rating is added to a PPL, the licence holder
shall
undertake pure tone audiometry examinations in accordance with the periodicity and the
standard required for class 1 medical certificate holders.
- A licence holder shall not at any time hold more than one medical certificate issued in
accordance with this Annex (Part-MED).
AMC1 MED.A.030 Medical certificates - ED Decision
2019/002/R
- A class 1 medical certificate includes the privileges and validities of class 2 and LAPL
medical
certificates.
- A class 2 medical certificate includes the privileges and validities of a LAPL medical
certificate.
MED.A.035 Application for a medical certificate - Regulation (EU)
2019/27
- Applications for a medical certificate shall be made in a form and manner established by the
competent authority.
- Applicants for a medical certificate shall provide the AeMC, AME or GMP, as applicable,
with:
- proof of their identity;
- a signed declaration:
- of medical facts concerning their medical history;
- as to whether they have previously applied for a medical certificate or have
undergone an aero-medical examination for a medical certificate and, if so,
by
whom and with what result;
- as to whether they have ever been assessed as unfit or had a medical
certificate
suspended or revoked.
- When applying for a revalidation or renewal of the medical certificate, applicants shall
present
the most recent medical certificate to the AeMC, AME or GMP, as applicable, prior to the
relevant aero-medical examinations.
AMC1 MED.A.035 Application for a medical certificate - ED Decision 2019/002/R
Except for initial applicants, the AeMC, AME or GMP should not start the aero-medical
examination
for the issue of the medical certificate where applicants do not present the most recent
medical
certificate, unless relevant information is received from the medical assessor of the
licensing
authority.
MED.A.040 Issuance, revalidation and renewal of medical
certificates - Regulation (EU) 2019/27
- A medical certificate shall only be issued, revalidated or renewed once the required
aeromedical examinations and assessments, as applicable, have been completed and the
applicant
has been assessed as fit.
- Initial issuance
- Class 1 medical certificates shall be issued by an AeMC.
- Class 2 medical certificates shall be issued by an AeMC or an AME.
- LAPL medical certificates shall be issued by an AeMC or an AME. They may also be
issued
by a GMP if so permitted under the national law of the Member State of the licensing
authority to which the application for the medical certificate has been made.
- Revalidation and renewal
- Class 1 and class 2 medical certificates shall be revalidated and renewed by an AeMC
or
an AME.
- LAPL medical certificates shall be revalidated and renewed by an AeMC or an AME.
They
may also be revalidated or renewed by a GMP if so permitted under the national law
of
the Member State of the licensing authority to which the application for the medical
certificate has been made.
- The AeMC, AME or GMP shall only issue, revalidate or renew a medical certificate if both of
the
following conditions have been met:
- the applicant has provided them with a complete medical history and, if required by
the
AeMC, AME or GMP, with results of medical examinations and tests conducted by the
applicant’s physician or any medical specialists;
- the AeMC, AME or GMP has conducted the aero-medical assessment based on the
medical examinations and tests as required for the relevant medical certificate to
verify
that the applicant complies with all the relevant requirements of this Annex
(Part-MED).
- The AME, AeMC or, in the case of referral, the medical assessor of the licensing authority
may
require the applicant to undergo additional medical examinations and investigations when
there is a clinical or epidemiological indication before the medical certificate is issued,
revalidated or renewed.
- The medical assessor of the licensing authority may issue or reissue a medical
certificate.
MED.A.045 Validity, revalidation and renewal of medical
certificates - Regulation (EU) 2019/27
- Validity
- Class 1 medical certificates shall be valid for a period of 12 months
- By derogation from point (1), the period of validity of class 1 medical certificates
shall be
6 months for licence holders who:
- are engaged in single-pilot commercial air transport operations carrying
passengers and have reached the age of 40;
- have reached the age of 60.
- Class 2 medical certificates shall be valid for a period of:
- 60 months, until the licence holder reaches the age of 40. A medical
certificate
issued prior to the licence holder reaching the age of 40 shall cease to be
valid after
the licence holder reaches the age of 42;
- 24 months, for licence holders aged between 40 and 50. A medical certificate
issued prior to the licence holder reaching the age of 50 shall cease to be
valid after
the licence holder reaches the age of 51;
- 12 months, for licence holders aged above 50.
- LAPL medical certificates shall be valid for a period of:
- 60 months, until the licence holder reaches the age of 40. A medical
certificate
issued prior to the licence holder reaching the age of 40 shall cease to be
valid after
the licence holder reaches the age of 42;
- 24 months, for licence holders aged above 40.
- The validity period of a medical certificate, including any associated examination
or
special investigation, shall be calculated from the date of the aero-medical
examination
in the case of initial issue and renewal, and from the expiry date of the previous
medical
certificate in the case of revalidation.
- Revalidation
Aero-medical examinations and assessments, as applicable, for the revalidation of a
medical certificate may be undertaken up to 45 days prior to the expiry date of the
medical certificate.
- Renewal
- If the holder of a medical certificate does not comply with point (b), a renewal
examination and assessment, as applicable, shall be required.
- In the case of class 1 and class 2 medical certificates:
- if the medical certificate has expired for less than 2 years, a routine
revalidation
aero-medical examination shall be performed;
- if the medical certificate has expired for more than 2 years but less than 5
years,
the AeMC or AME shall only conduct the renewal aero-medical examination
after
assessment of the aero-medical records of the applicant;
- if the medical certificate has expired for more than 5 years, the
aero-medical
examination requirements for initial issue shall apply and the assessment
shall be
based on the revalidation requirements.
- In the case of LAPL medical certificates, the AeMC, AME or GMP shall assess the
medical
history of the applicant and perform the aero-medical examinations and assessments,
as
applicable, in accordance with points MED.B.005 and MED.B.095.
MED.A.046 Suspension or revocation of medical certificates - Regulation (EU)
2019/27
- A medical certificate may be suspended or revoked by the licensing authority.
- Upon suspension of the medical certificate, the holder shall return the medical certificate
to the
licensing authority on request of that authority.
- Upon revocation of the medical certificate, the holder shall immediately return the medical
certificate to the licensing authority.
MED.A.050 Referral - Regulation (EU) 2019/27
- If an applicant for a class 1 or class 2 medical certificate is referred to the medical
assessor of
the licensing authority in accordance with point MED.B.001, the AeMC or AME shall transfer
the
relevant medical documentation to the licensing authority.
- If an applicant for a LAPL medical certificate is referred to an AME or AeMC in accordance
with
point MED.B.001, the GMP shall transfer the relevant medical documentation to the AeMC or
AME.